The Mel Robbins PodcastThe Ultimate Guide to Women’s Sexual Health, Hormone Replacement Therapy (HRT) & Menopause
CHAPTERS
- 3:35 – 5:45
Who Dr. Rachel Rubin is & why women’s sexual health gets overlooked
Mel introduces Dr. Rachel Rubin, a urologist and sexual medicine expert, and they clarify what urology/sexual medicine covers for women. Dr. Rubin explains how training gaps and siloed care ("gynecology = women") cause sexual and urinary symptoms to be missed or dismissed.
- 5:45 – 8:17
Harmful myths & dismissive advice women are told about pain, libido, and aging
Dr. Rubin lists common, damaging advice women receive when they report painful sex or low desire. She reframes many symptoms as treatable medical issues with biological drivers—not something to "push through" or accept as aging.
- 8:17 – 14:36
Hormones across the lifespan: puberty, pregnancy/postpartum, breastfeeding, perimenopause & menopause
They map hormone patterns to life stages, emphasizing how dramatic shifts influence the brain, mood, vulvovaginal tissue, and urinary tract. Dr. Rubin highlights postpartum and breastfeeding as a temporary low-estrogen state that can mimic menopause symptoms.
- 14:36 – 21:16
Recurrent UTIs: the missing hormonal root cause (and why antibiotics aren’t the full solution)
Dr. Rubin explains that recurrent UTIs are often driven by hormonal changes that disrupt the vaginal/bladder microbiome and tissue resilience. Antibiotics treat infection, but prevention requires addressing underlying drivers—including hormones.
- 21:16 – 30:11
GSM explained simply: pH, thinning tissue, burning, painful sex, and “UTI-like” symptoms
They define Genitourinary Syndrome of Menopause (GSM) as hormone-related changes affecting vulva, vagina, bladder, and urethra. Dr. Rubin describes how rising pH, thinning tissue, and irritation lead to dryness, pain, urgency/frequency, and symptoms often mistaken for infection.
- 30:11 – 33:19
Why systemic HRT often isn’t enough & the case for adding local vaginal therapy
Mel shares she’s on systemic estrogen/progesterone; Dr. Rubin explains many patients still need local vaginal treatment for GSM symptoms. Vaginal therapy is positioned as foundational, like “sunscreen,” taking a couple months for maximal benefit.
- 33:19 – 41:00
Vaginal estrogen options & practical use: cream vs tablet vs ring (dose, ease, cost)
Dr. Rubin walks through common delivery methods and how to choose based on preference, dexterity, and lifestyle. They discuss simple dosing (often twice weekly) and emphasize affordability and real-world adherence.
- 41:00 – 47:38
The ICU story & the FDA label change: how black-box warnings blocked lifesaving care
Dr. Rubin shares her mother’s ICU experience to show how fear-based labeling and clinician unfamiliarity prevented timely care—even in a hospital setting. She then explains the advocacy effort that led to removing incorrect boxed warnings from vaginal hormone products.
- 47:38 – 55:39
Who should consider vaginal estrogen or vaginal DHEA (including breast cancer and lactation)
They outline broad candidacy for local vaginal hormones via shared decision-making, stressing quality of life and infection prevention. Dr. Rubin introduces Genitourinary Syndrome of Lactation (GSL) and notes vaginal hormones can be appropriate during breastfeeding.
- 55:39 – 1:01:21
Birth control, spironolactone, and “testosterone blockade” as hidden drivers of pain and UTIs
Dr. Rubin describes how some hormonal contraceptives and anti-androgen acne treatments can lower testosterone and affect genital tissue and microbiome. They discuss why certain IUDs may be less disruptive and why clinicians should evaluate recurrent UTIs through a hormonal lens.
- 1:01:21 – 1:17:40
How hormones influence UTIs: receptors, microbiome shifts, and sex-related pH changes
They connect anatomy and physiology: bladder/vagina are receptor-rich tissues sensitive to estrogen/testosterone levels. Dr. Rubin explains how higher pH and dysbiosis increase infection risk and why irritation can feel like a UTI even when cultures are negative.
- 1:17:40 – 1:23:21
Reframing HRT after the 2002 scare & introducing the “4 buckets” hormone framework
Dr. Rubin recounts how the Women’s Health Initiative messaging and media coverage created decades of fear and training gaps. She then offers a practical framework: systemic estrogen, systemic progesterone, systemic testosterone, and localized vaginal hormones as separate tools.
- 1:23:21 – 1:36:36
Testosterone for women: benefits, prescribing realities, and DHEA vs estrogen vs systemic testosterone
They discuss testosterone as a human hormone and review why the U.S. lacks an FDA-approved product for women despite international approvals and global consensus statements. Dr. Rubin explains practical dosing using male formulations and what improvements patients commonly report.
- 1:36:36
Clitoral adhesions, vulvar vestibule pain, pelvic floor tightness: the anatomy most women were never taught
Dr. Rubin explains clitoral anatomy, clitoral adhesions (reported in a notable portion of patients), and how simple procedures can improve pain and function. She also defines the vulvar vestibule and pelvic floor dysfunction as leading, treatable causes of painful sex.
Self-advocacy at the doctor: how to use a 10-minute visit and build a ‘pit crew’
They close with practical advice for patients and clinicians: prepare, use respectful framing, and seek providers willing to learn or refer. Dr. Rubin shares education resources, documentaries, and encourages ongoing learning and community-driven change.
Get more out of YouTube videos.
High quality summaries for YouTube videos. Accurate transcripts to search & find moments. Powered by ChatGPT & Claude AI.
Add to Chrome